AMETEK INC/ (AME): Results of Operations and Financial Condition
AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Aug 4, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30, 2026. AMETEK’s second quarter 2026 sales were a record $2
How this was made
The 30-second read
Why it matters
The key tradable items are the raised full-year adjusted EPS range and the Q3 adjusted EPS range, supported by record sales, record GAAP and adjusted EPS, higher operating margins, and strong orders growth.
Market read
Record Q2 performance plus a higher FY 2026 adjusted EPS range is a direct catalyst for earnings expectations and valuation.
What to watch
The release emphasizes adjusted metrics; traders may scrutinize GAAP-to-adjusted differences and whether cash flow conversion remains elevated into H2.
AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance
Record second-quarter sales, GAAP operating income, GAAP diluted EPS and adjusted diluted EPS were accompanied by 15% sales growth, 17% adjusted EPS growth, 18% adjusted operating-income growth, 28% orders growth and higher full-year adjusted EPS guidance.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net salesGAAP | $2,044,397 (In thousands) | – | 15% |
| Cost of salesGAAP | 1,309,356 (In thousands) | – | – |
| Selling, general and administrativeGAAP | 206,848 (In thousands) | – | – |
| Total operating expensesGAAP | 1,516,204 (In thousands) | – | – |
| Operating incomeGAAP | $528,193 (In thousands) | – | – |
| Adjusted operating incomenon-GAAP | $544,397 (In thousands) | – | 18% |
| Operating marginsnon-GAAP | 26.6% | – | up 60 basis points |
| Interest expenseGAAP | $(30,101) (In thousands) | – | – |
| Other (expense) income, netGAAP | $(5,720) (In thousands) | – | – |
| Income before income taxesGAAP | 492,372 (In thousands) | – | – |
| Provision for income taxesGAAP | 85,476 (In thousands) | – | – |
| Net incomeGAAP | $406,896 (In thousands) | – | – |
| Diluted earnings per shareGAAP | $1.77 | – | – |
| Adjusted diluted earnings per sharenon-GAAP | $2.09 | – | 17% |
| Basic earnings per shareGAAP | $1.78 | – | – |
| Diluted sharesGAAP | 229,855 (In thousands) | – | – |
| Basic sharesGAAP | 229,086 (In thousands) | – | – |
| Cash provided by operating activitiesGAAP | $483,693 (In thousands) | – | 35% |
| Capital expendituresGAAP | $(32,012) (In thousands) | – | – |
| Free cash flownon-GAAP | $451,681 (In thousands) | – | – |
| Free cash flow conversionnon-GAAP | 111% | – | – |
| Orders growthother | 28% | – | – |
| Net sales, six months ended June 30GAAP | $3,972,834 (In thousands) | – | – |
| Operating income, six months ended June 30GAAP | $1,043,129 (In thousands) | – | – |
| Net income, six months ended June 30GAAP | $806,253 (In thousands) | – | – |
| Diluted earnings per share, six months ended June 30GAAP | $3.51 | – | – |
| Basic earnings per share, six months ended June 30GAAP | $3.52 | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Electronic InstrumentsSales growth in the quarter was balanced between organic growth and contributions from recent acquisitions, with excellent orders growth highlighted by semiconductor and commercial aerospace markets. | $1,321,153 (In thousands) | – | 14% |
| ElectromechanicalStrong organic sales growth resulted in sizeable profit growth and 290 basis points of core margin expansion; orders growth was broad-based with notable strength in medtech, defense and automation markets. | $723,244 (In thousands) | – | 17% |
Third Quarter and Full Year 2026 outlook
- RevenueFor 2026, overall sales are expected to be up approximately 10% versus 2025. For the third quarter of 2026, overall sales are expected to be up high single digits on a percentage basis compared to the third quarter of 2025.
- NoteFor 2026, adjusted earnings per diluted share are expected to be in the range of $8.20 to $8.30, up 10% to 12% over the comparable basis for 2025.
- NoteFor the third quarter of 2026, adjusted earnings are anticipated to be in the range of $2.08 to $2.10 per share, up 10% to 11% compared to the third quarter of 2025.
Capital returns
- Dividends per share: $0.34 for the three months ended June 30, 2026, compared with $0.31 for the three months ended June 30, 2025.
- Dividends per share: $0.68 for the six months ended June 30, 2026, compared with $0.62 for the six months ended June 30, 2025.
What drove it
- Strong organic sales growth.
- Contributions from recent acquisitions.
- Orders grew 28% in the quarter.
- EIG orders growth was highlighted by semiconductor and commercial aerospace markets.
- EMG orders strength was notable in medtech, defense and automation markets.
- Core margin expansion was 110 basis points companywide, 40 basis points at EIG and 290 basis points at EMG.
Concerns
- Interest expense was $(30,101) (In thousands), compared with $(16,857) (In thousands) in the prior-year quarter.
- The company identifies risks related to future acquisitions and integration, international sales and operations, supply chain disruptions, tariffs, trade disputes, currency conditions, raw-material availability, liquidity and general economic conditions.
What to watch
- Execution against full-year overall sales growth expected to be up approximately 10% versus 2025.
- Third-quarter overall sales growth expected to be up high single digits on a percentage basis compared to the third quarter of 2025.
- Third-quarter adjusted earnings anticipated to be $2.08 to $2.10 per share.
- Sustainability of exceptional orders growth and the cited demand in semiconductor, commercial aerospace, medtech, defense and automation.
- Conversion of operating performance into free cash flow following 111% free cash flow conversion in the quarter.
Balance sheet and cash flow
- Cash and cash equivalents were $495,446 (In thousands) at June 30, 2026, compared with $457,951 (In thousands) at December 31, 2025.
- Short-term borrowings and current portion of long-term debt, net were $980,633 (In thousands) at June 30, 2026, compared with $1,208,975 (In thousands) at December 31, 2025.
- Long-term debt, net was $1,055,541 (In thousands) at June 30, 2026, compared with $1,074,334 (In thousands) at December 31, 2025.
- Cash provided by operating activities was $483,693 (In thousands), compared with $359,089 (In thousands) in the prior-year quarter.
- Free cash flow was $451,681 (In thousands), compared with $329,820 (In thousands) in the prior-year quarter.
- Free cash flow conversion was 111%, compared with 92% in the prior-year quarter.
Analysis
AMETEK reported record second-quarter sales of $2,044,397 (In thousands), up 15%, with record GAAP operating income of $528,193 (In thousands) and record GAAP diluted EPS of $1.77. Adjusted diluted EPS was $2.09, up 17%, while adjusted operating income rose 18% to $544,397 (In thousands). The release attributes the performance to strong organic sales growth, recent acquisitions and operating execution.
Both operating segments expanded. Electronic Instruments generated $1,321,153 (In thousands) of sales, up 14%, and adjusted segment operating income of $384,718 (In thousands), up 12%. Management described growth as balanced between organic activity and recent acquisitions, with orders strength in semiconductor and commercial aerospace. Electromechanical sales were $723,244 (In thousands), up 17%, and adjusted segment operating income was $190,525 (In thousands), up 32%; management cited organic growth and demand in medtech, defense and automation.
Margins and cash generation were notable. Company operating margins were 26.6%, up 60 basis points, and management cited 110 basis points of core margin expansion. Free cash flow was $451,681 (In thousands), versus $329,820 (In thousands) in the prior-year quarter, and free cash flow conversion reached 111%. Cash and cash equivalents were $495,446 (In thousands) at June 30, 2026, while short-term borrowings and current portion of long-term debt, net were $980,633 (In thousands) and long-term debt, net was $1,055,541 (In thousands).
The company raised its full-year adjusted EPS outlook to $8.20 to $8.30 from the prior guidance range of $7.94 to $8.14 per diluted share stated in the current release. Full-year sales are now expected to be up approximately 10% versus 2025. For the third quarter, AMETEK expects overall sales to be up high single digits on a percentage basis and adjusted earnings of $2.08 to $2.10 per share. The guide places continued orders momentum, organic growth, acquisition contributions and margin execution at the center of the second-half outlook.
Management, verbatim
AMETEK delivered superb results in the second quarter. Strong organic sales growth, contributions from recent acquisitions, and outstanding operating performance led to high-teens earnings growth, excellent 110 basis points of core margin expansion and record operating performance.
David A. Zapico, Chairman and Chief Executive Officer
EIG generated outstanding results in the second quarter with mid-teens sales growth, sizeable orders growth and excellent operating performance.
David A. Zapico, Chairman and Chief Executive Officer
EMG delivered exceptional results in the second quarter. Strong organic sales growth resulted in sizeable profit growth and 290 basis points of core margin expansion.
David A. Zapico, Chairman and Chief Executive Officer
Not in the filing
stated, not guessed- Previous-release outlook was not provided; therefore no metric-by-metric comparison of actual results with prior guidance is available.
- GAAP gross profit and GAAP gross margin were not reported.
- Quarter-over-quarter comparisons were not reported.
- Share repurchases were not reported.
- Forward guidance for gross margin, operating expenses and tax rate was not reported.
- A specific percentage change for GAAP operating income, GAAP net income, GAAP diluted EPS, free cash flow and six-month metrics was not reported.
- Six-month cash flow metrics, including cash provided by operating activities, capital expenditures and free cash flow, were not reported.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
This is an SEC Form 8-K (Item 2.02) with AMETEK’s Q2 2026 results and updated Q3 and full-year 2026 outlook.
Ticker impact
AMETEK reported record Q2 2026 sales of $2.04B, GAAP EPS $1.77, and raised full-year adjusted EPS guidance to $8.20 to $8.30.
Likely positive near-term bias as traders price the higher 2026 EPS range and strong order growth.
The filing is a primary disclosure (8-K) with specific, time-bound guidance changes and multiple corroborating operating metrics (orders +28%, core margin expansion, strong cash flow).
Market effects
Strength in orders and margins supports the broader industrial technology demand narrative, particularly for electronics and electromechanical end markets.
No explicit regional demand shock cited; impact is primarily company-specific.
Secular infrastructure and aerospace/semiconductor demand tailwinds are referenced, but no new macro/regional data is provided.
Counterpoint
Guidance upside may already be partially anticipated; investors could focus on sustainability of order growth and integration-related costs.
Key entities
- public_companyAMETEK, Inc.
Industrial technology company reporting Q2 2026 results and raising 2026 guidance in an 8-K.
- business_segmentElectronic Instruments Group (EIG)
Segment with Q2 sales $1.32B and adjusted operating income up 12%.
- business_segmentElectromechanical Group (EMG)
Segment with Q2 sales $723.2M and adjusted operating income up 32%.
- executiveDavid A. Zapico
Chairman and CEO quoted on record results, orders growth, and guidance.
